5 Potential Winners In The ‘New Normal’ Economy

These 5 companies could give your portfolio a boost. Here’s why.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

city

This week saw the departure of Sir Charlie Bean, Deputy Governor of the Bank of England, and in his final interview he stated that the ‘new normal’ interest rate could be as low as 2.5%.

Part of the reason for this is the vast amount of borrowing that UK businesses and individuals currently have, as well as the economy’s sluggish response to the credit crunch, which together mean that an ‘old normal’ rate of 5% may be a long way off.

With that in mind, here are five shares that could benefit from continued low rates.

GlaxoSmithKline

The last few years have been tough for savers, with savings rates being very low. The ‘new normal’ rate of 2.5%, although better, remains relatively unattractive. So shares that offer both a high yield and impressive dividend growth prospects could turn out to be winners.

One such example is GlaxoSmithKline (LSE: GSK). It currently yields 5.2% but its highly attractive drug pipeline means that long-term profitability prospects are very encouraging. As a result, GlaxoSmithKline’s dividend per share could increase at a brisk pace and make the shares more highly demanded, which could also help the share price to head northwards.

British American Tobacco

One beneficiary of low interest rates are companies with high debt levels. Such a  company is British American Tobacco (LSE: BATS), which currently has a debt to equity ratio of 176% — in other words, for every £1 of equity, the business has £1.76 of debt.

Although this seems high, the stability of British American Tobacco’s revenues makes it manageable, while a low interest rate should help to reduce interest charges, thereby increasing company profits. As with GlaxoSmithKline, a yield of 4.2% should also lead to buoyant demand for shares in the company.

The Retail Sector

Clearly, under ‘new normal’ conditions of low interest rates, there is less incentive to save and more incentive to spend. Therefore, retailers such as Sports Direct (LSE: SPD), Marks & Spencer (LSE: MKS) and Debenhams (LSE: DEB) should stand to benefit.

Certainly, Sports Direct is the best performer of the three at present, with the company set to report five consecutive years of earnings growth next year. It also remains attractive when its valuation and growth potential are taken into account, with a price to earnings growth (PEG) ratio of just 0.7 providing evidence of this.

Meanwhile, Debenhams and Marks & Spencer continue to struggle with their respective top-lines. The turnaround story at Marks & Spencer has disappointed many investors, but progress is being made, albeit slowly and its shares continue to offer strong income — a 4.1% yield — and good value  — a price to earnings (P/E) ratio of 12.7 —  at current levels.

Although shares in Debenhams have fallen heavily over the last six months, it too has potential. Recent news included Sports Direct and Costa Coffee concessions within stores, as well as a renewed focus on the company’s multi-channel offering and international expansion. Trading on a P/E of just 9.3, its shares offer great long-term value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter owns shares in GlaxoSmithKline and Marks & Spencer. The Motley Fool has recommended GlaxoSmithKline.

More on Investing Articles

Investing Articles

£10k in an ISA? I’d use it to aim for an annual £1k second income

Want a second income without having to take on a second job? With a bit of money up front, and…

Read more »

Investing Articles

Up over 100% in price in 10 years! Big Yellow also offers passive income from dividends

Oliver loves the look of Big Yellow to generate a healthy passive income from its generous dividends. He thinks storage…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

If I put £750 into a SIPP every month, could I retire a millionaire?

Ben McPoland considers a high-quality FTSE 100 stock that could contribute towards building him a large SIPP portfolio in future.

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

Down 8.5% this month, is the Aviva share price too attractive to ignore?

It’s time to look into Aviva and the insurance sector while the share price is pulling back from year-to-date highs.

Read more »

Investing Articles

Here’s where I see Vodafone’s share price ending 2024

Valued at just twice its earnings, is the Vodafone share price a bargain or value trap? Our writer explores where…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

The Darktrace share price jumped 20% today. Here’s why!

After the Darktrace share price leapt by a fifth in early trading, our writer explains why -- and what it…

Read more »

Dividend Shares

850 shares in this dividend giant could make me £1.1k in passive income

Jon Smith flags up one dividend stock for passive income that has outperformed its sector over the course of the…

Read more »